SavedAdd your journal

Journals / Journal of Health Sciences and Medicine / 2026 / Volume: 4 Issue: 5

Assessment of Tp-e interval, Tp-e/QT, and Tp-e/QTc ratios, in patients with COVID-19 infected with or without pneumonia

Şaban Keleşoğlu(ERCIYES UNIVERSITY, SCHOOL OF MEDICINE)0000-0001-6249-9220
Yücel Yılmaz(Kayseri City Training and Research Hospital, Department of Cardiology)0000-0003-2340-027X
Pages
—
Publication Date
2021-09-05
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our present study showed that Tp-e interval, Tp-e/QT, Tp-e/QTc ratio were prolonged in COVID-19 infected patients with pneumonia

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: COVID-19 infection has the potential to affect the cardiovascular system as well as respiratory disease.
📊
Key Findings & Data:The goal of this study is to the evaluation of Tp-e interval, Tp-e/QT, and Tp-e/QTc ratios, in patients with Covid-19 infected with or without pneumonia.
💡
Conclusion & Impact:Conclusion: Our present study showed that Tp-e interval, Tp-e/QT, Tp-e/QTc ratio were prolonged in COVID-19 infected patients with pneumonia
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:COVID-19 · Tp-e interval · Tp-e/QT and Tp-e/QTc

Abstract

Objective: COVID-19 infection has the potential to affect the cardiovascular system as well as respiratory disease. Recent studies have suggested that Tp-e interval, Tp-e/QT, and Tp-e/QTc ratios may be associated with ventricular arrhythmias. The goal of this study is to the evaluation of Tp-e interval, Tp-e/QT, and Tp-e/QTc ratios, in patients with Covid-19 infected with or without pneumonia. Material and Method: 118 patients with COVID-19 infection were divided into 2 groups: patients with and without pneumonia, the control group consisted of 39 people. The Tp-e interval, Tp-e/QT, and Tp-e/QTc ratio were gauged by the 12-lead electrocardiogram. Results: Tp-e interval, Tp-e/QT, Tp-e/QTc ratio were considerably high in COVID-19 patients with pneumonia, contrasted to the without pneumonia patients. (p < 0.01, p < 0.01, p <0,01, respectively) whereas the same parameters were similar to the control group in COVID-19 infected patients without pneumonia. (p=0.258, p=0.249, p=0,056, respectively). Correlation analysis revealed a significant and positive correlation between CRP with Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc ratio. There was the same correlation relationship between WBC with Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc ratio. Conclusion: Our present study showed that Tp-e interval, Tp-e/QT, Tp-e/QTc ratio were prolonged in COVID-19 infected patients with pneumonia

🔖

Cite This Article

Keleşoğlu, Ş., Yılmaz, Y. (2021). Assessment of Tp-e interval, Tp-e/QT, and Tp-e/QTc ratios, in patients with COVID-19 infected with or without pneumonia. Journal of Health Sciences and Medicine, Volume: 4 Issue: 5. https://doi.org/10.32322/jhsm.944836

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (29)

  1. Wu Z, McGoogan JM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases from the Chinese Center for Disease Control and Prevention. JAMA 2020. doi: 10.1001/jama 2020. 2648.
  2. Özdemir Ö. Coronavirus Disease 2019 (COVID-19): Diagnosis and Management. Erciyes Med J 2020; 42: 242-7.
  3. Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res 2020; 116: 1666-87.
  4. Kelesoglu S, Yilmaz Y, Ozkan E, et al. New onset atrial fibrilation and risk faktors in COVID-19. J Electrocardiol 2021; 65: 76-81.
  5. Liu K, Fang YY, Deng Y, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl) 2020; 133: 1025-31.
  6. Elming H, Holm E, Jun L, et al. The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens. Eur Heart J 1998; 19: 1391-400.
  7. Tse G, Yan BP. Traditional and novel electrocardiographic conduction and repolarization markers of sudden cardiac death. Europace 2017; 19: 712-21.
  8. Kors JA, Ritsema van Eck HJ, van Herpen G. The meaning of the Tp-Te interval and its diagnostic value. J Electrocardiol 2008; 41: 575-80
  9. Castro Hevia J, Antzelevitch C, Tornes Barzaga F, et al. Tpeak-T end and T peak-T end dispersion as risk factors for ventricular tachycardia/ventricular fibrillation in patients with the Brugada syndrome. J Am Coll Cardiol 2006; 47: 1828-34.
  10. T.C. Ministry of Health General Directorate of Public Health, COVID-19 (Sars-Cov2 Infection) Directory, Coronavirus Scientific Advisory Board, Turkey 2020
  11. Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J 2019; 40: 237-69
  12. Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012; 33: 1635–701.
  13. Gupta P, Patel C, Patel H, et al. Tp-e/QT ratio as an index of arrhythmogenesis. J Electrocardiol 2008; 41: 567-74.
  14. Kors JA, van Herpen G, van Bemmel JH. QT dispersion as an attribute of T-loop morphology. Circulation 1999; 99: 1458-63.
  15. Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol 2020; 5: 13–364.
  16. Barr CS, Naas A, Freeman M, Lang CC, Struthers AD. QT dispersion and sudden unexpected death in chronic heart failure. The Lancet 1994; 343: 327-9.
  17. Antzelevitch C, Sicouri S, Di Diego JM, et al. Does Tpeak–Tend provide an index of transmural dispersion of repolarization? Heart Rhythm 2007; 4: 1114-6.
  18. Tomasz J. Guzik et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res 2020.
  19. Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J 2020.
  20. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506
  21. Ucar FM, Ozturk C, Yılmaztepe MA. Evaluation of Tp-e Interval, Tp-e/QT Ratio and Tp-e/QTc Ratio in Patients with Acute Myocarditis. BMC Cardiovasc Disord 2019; 19: 232
  22. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol 2020.
  23. Brouillette J, Cyr S, Fiset C. Mechanisms of arrhythmia and sudden cardiac death in patients with HIV infection. Can J Cardiol 2019; 35: 310-9.
  24. Lagrand WK, Visser CA, Hermens WT,et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation 1999; 100: 96-102.
  25. Kushner I. The phenomenon of the acute phase response. Ann New York Acad Sci 1982; 389: 39-48
  26. Soto-Gomez N, Anzueto A, Waterer GW, Restrepo MI, Mortensen EM. Pneumonia: an arrhythmogenic disease? Am J Med 2013; 126: 43-8.
  27. Restrepo MI, Reyes LF. Pneumonia as a cardiovascular disease. Respirology 2018; 23: 250-9.
  28. Corrales-Medina VF, Musher DM, Shachkina S, Chirinos JA. Acute pneumonia and the cardiovascular system. Lancet 2013; 381: 496–505.
  29. Öztürk F, Karaduman M, Çoldur R, İncecik Ş, Güneş Y, Tuncer M. Interpretation of arrhythmogenic effects of COVID-19 disease through ECG. Aging Male 2020: 1-4.